Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 5620693, 11 pages
https://doi.org/10.1155/2017/5620693
Research Article

Acyclic Sesquiterpenes from the Fruit Pericarp of Sapindus saponaria Induce Ultrastructural Alterations and Cell Death in Leishmania amazonensis

1Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Estadual de Maringá, Avenida Colombo 5790, Jd. Universitário, Maringá, PR, Brazil
2Laboratório de Inovação Tecnológica no Desenvolvimento de Fármacos e Cosméticos, Universidade Estadual de Maringá, Avenida Colombo 5790, Jd. Universitário, Maringá, PR, Brazil

Correspondence should be addressed to Izabel Cristina Piloto Ferreira

Received 5 March 2017; Revised 29 June 2017; Accepted 19 July 2017; Published 22 August 2017

Academic Editor: Juntra Karbwang

Copyright © 2017 Amanda Louzano Moreira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Lovato, B. L. Pelegrini, J. Rodrigues, A. J. Braz de Oliveira, and I. C. Piloto Ferreira, “Seed oil of Sapindus saponaria L. (Sapindaceae) as potential C16 to C22 fatty acids resource,” Biomass and Bioenergy, vol. 60, pp. 247–251, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. O. A. A. Guirado, “Potencial medicinal del gênero SapindusL. (Sapindaceae) y de lá especie Sapindus saponariaL,” Revista Cubana Planta Medicinal, vol. 10, pp. 3-4, 2005. View at Google Scholar
  3. A. Sharma, S. C. Sati, D. Sati, Maneesha, and S. K. Kothiyal, “Chemical constituents and bio activities of genus Sapindus,” International Journal of Research in Ayurveda and Pharmacy, no. 2, pp. 403–409, 2011. View at Google Scholar
  4. M. Murgu and E. Rodrigues Filho, “Dereplication of glycosides from Sapindus saponariausing liquid cromatography-mass spectrometry,” Journal of the Brazilian Chemical Society, vol. 17, no. 7, pp. 1291–1290, 2006. View at Google Scholar
  5. L. Maes, D. Vanden Berghe, N. Germonprez et al., “In Vitro and In Vivo Activities of a Triterpenoid Saponin Extract (PX-6518) from the Plant Maesa balansae against Visceral Leishmania Species,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 1, pp. 130–136, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. I. da Luz, M. Vermeersch, M. Deschacht et al., “In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 2, Article ID dkq444, pp. 350–353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ray, H. K. Majumder, A. K. Chakravarty, S. Mukhopadhyay, R. R. Gil, and G. A. Cordell, “Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoisomerase I from Leishmania donovani,” Journal of Natural Products, vol. 59, no. 1, pp. 27–29, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Di Giorgio, M. Lamidi, F. Delmas, G. Balansard, and E. Ollivier, “Antileishmanial activity of quinovic acid glycosides and cadambine acid isolated from Nauclea diderrichii,” Planta Medica, vol. 72, no. 15, pp. 1396–1402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. W. M. Abdel-Mageed, E. Y. Backheet, A. A. Khalifa, Z. Z. Ibraheim, and S. A. Ross, “Antiparasitic antioxidant phenylpropanoids and iridoid glycosides from Tecoma mollis,” Fitoterapia, vol. 83, no. 3, pp. 500–507, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Grevelink and E. A. Lerner, “Leishmaniasis,” Journal of the American Academy of Dermatology, vol. 34, no. 2 I, pp. 257–272, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Genaro, “Leishmaniose Tegumentar Americana,” in Parasitologia Humana, D. P. Neves, Ed., pp. 41–60, Atheneu, São Paulo, Brazil, 9th edition, 1998. View at Google Scholar
  12. World Health Organization, Parasitic Disease, World Health Organization, 2015, http://www.who.int/leishmaniasis/en/index.html.
  13. F. Chappuis, E. Alirol, D. T. Worku, Y. Mueller, and K. Ritmeijer, “High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in east africa and rationale for switch to liposomal amphotericin B,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 1, pp. 455-456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. R. L. M. Neto, L. M. A. Sousa, C. S. Dias, J. M. B. Filho, M. R. Oliveira, and R. C. B. Q. Figueiredo, “Morphological and physiological changes in Leishmania promastigotes induced by yangambin, a lignan obtained from Ocotea duckei,” Experimental Parasitology, vol. 127, no. 1, pp. 215–221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Seifert and S. L. Croft, “In vitroand in vivointeractions between miltefosine and other antileishmanial drugs,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 1, pp. 73–79, 2006. View at Google Scholar
  16. V. Kaplum, J. Cogo, D. P. Sangi, T. Ueda-Nakamura, A. G. Corrêa, and C. V. Nakamura, “In vitro and in vivo activities of 2,3-diarylsubstituted quinoxaline derivatives against Leishmania amazonensis,” Antimicrobial Agents and Chemotherapy, vol. 60, no. 6, pp. 3433–3444, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  18. E. A. Britta, D. B. Scariot, H. Falzirolli et al., “Cell death and ultrastructural alterations in Leishmania amazonensis caused by new compound 4-Nitrobenzaldehyde thiosemicarbazone derived from S-limonene,” BMC Microbiology, vol. 14, no. 1, article no. 236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. D. B. Scariot, E. A. Britta, A. L. Moreira et al., “Induction of Early Autophagic Process on Leishmania amazonensis by Synergistic Effect of Miltefosine and Innovative Semi-synthetic Thiosemicarbazone,” Front. Microbiol, no. 8, p. 255, 2017. View at Google Scholar
  20. J. Kleeff, M. Kornmann, H. Sawhney, and M. Korc, “Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells,” International Journal of Cancer, vol. 89, no. 2, pp. 399–407, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. M. L. R. Lim, T. Minamikawa, and P. Nagley, “The protonophore CCCP induces mitochondrial permeability transition without cytochrome c release in human osteosarcoma cells,” FEBS Letters, vol. 503, no. 1, pp. 69–74, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. F. P. Garcia, J. Henrique da Silva Rodrigues, Z. U. Din et al., “A3K2A3-induced apoptotic cell death of Leishmania amazonensis occurs through caspase- and ATP-dependent mitochondrial dysfunction,” Apoptosis, vol. 22, no. 1, pp. 57–71, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Paris, P. M. Loiseau, C. Bories, and J. Bréard, “Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 3, pp. 852–859, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Jimenez, R. Paredes, M. A. Sosa, and N. Galanti, “Natural programmed cell death in T. cruzi epimastigotes maintained in axenic cultures,” Journal of Cellular Biochemistry, vol. 105, no. 3, pp. 688–698, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Lazarin-Bidóia, V. C. Desoti, T. Ueda-Nakamura, B. P. Dias Filho, C. V. Nakamura, and S. O. Silva, “Further evidence of the trypanocidal action of eupomatenoid-5: Confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction in trypanothione reductase activity,” Free Radical Biology and Medicine, vol. 60, pp. 17–28, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. P. R. Murray, K. S. Rosenthal, G. S. Kobayashi, and M. A. Pfaller, Microbiologia Médica, Guanabara Koogan, Rio de Janeiro, 6th edition, 2000.
  27. B. P. da Silva, D. A. Cortez, T. Y. Violin et al., “Antileishmanial activity of a guaianolide from Tanacetum parthenium (L.) schultz bip,” Parasitology International, vol. 59, no. 4, pp. 643–646, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. D. Kinghorn, “Pharmacognosy in the 21st century,” Journal of Pharmacy and Pharmacology, vol. 53, no. 2, pp. 135–148, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Samuelsson, Drugs of Natural Origin: a Textbook of Pharmacognosy, Swedish Pharmaceutical Press, Stockholm, 5th edition, 2004.
  30. M. J. Balunas and A. D. Kinghorn, “Drug discovery from medicinal plants,” Life Sciences, vol. 78, no. 5, pp. 431–441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Baumann, G. Stoya, A. Völkner, W. Richter, C. Lemke, and W. Linss, “Hemolysis of human erythrocytes with saponin affects the membrane structure,” Acta Histochemica, vol. 102, no. 1, pp. 21–35, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. S. W. Perry, J. P. Norman, J. Barbieri, E. B. Brown, and H. A. Gelbard, “Mitochondrial membrane potential probes and the proton gradient: a practical usage guide,” BioTechniques, vol. 50, no. 2, pp. 98–115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Brauchle, S. Thude, S. Y. Brucker, and K. Schenke-Layland, “Cell death stages in single apoptotic and necrotic cells monitored by Raman microspectroscopy,” Scientific Reports, vol. 4, article no. 4698, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. A. J. Kowaltowski and A. E. Vercesi, “Mitochondrial damage induced by conditions of oxidative stress,” Free Radical Biology and Medicine, no. 26, pp. 463–471, 1999. View at Google Scholar
  35. S. Elmore, “Apoptosis: a review of programmed cell death,” Toxicologic Pathology, vol. 35, no. 4, pp. 495–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. K. Au, H. Bayir, P. M. Kochanek, and R. S. B. Clark, “Evaluation of autophagy using mouse models of brain injury,” Biochimica et Biophysica Acta - Molecular Basis of Disease, vol. 1802, no. 10, pp. 918–923, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. C. Hewitt and P. H. Seeberger, “Solution and solid-support synthesis of a potential leishmaniasis carbohydrate vaccine,” Journal of Organic Chemistry, vol. 66, no. 12, pp. 4233–4243, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Menger, E. Vacchelli, S. Adjemian et al., “Cardiac glycosides exert anticancer effects by inducing immunogenic cell death,” Science Translational Medicine, vol. 4, no. 143, Article ID 143ra99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Delmas, C. Di Giorgio, R. Elias et al., “Antileishmanial activity of three saponins isolated from ivy, α- hederin, β-hederin and hederacolchiside A1, as compared to their action on mammalian cells cultured in vitro,” Planta Medica, vol. 66, no. 4, pp. 343–347, 2000. View at Publisher · View at Google Scholar · View at Scopus